Evidence map›Paper›PMID 29073103›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2017

Packaging and transfer of mitochondrial DNA via exosomes regulate escape from dormancy in hormonal therapy-resistant breast cancer.

Pasquale Sansone, Claudia Savini, Ivana Kurelac, Qing Chang, Laura Benedetta Amato, Antonio Strillacci, Anna Stepanova, Luisa Iommarini, Chiara Mastroleo, Laura Daly and 11 more

Erratum issuedOpen access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 482 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
482citing papers in PubMed, 4 pooled it
22.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

482 citing papers in PubMed, 4 syntheses or guidelines pooled it, 704 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Article
  6. Biology and Therapeutic Potential of Exosomes, Targeted Drug Delivery.International journal of molecular sciences · 2026
    Review
  7. Review
  8. Article
  9. Review
  10. Review
  11. Review
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Article

422 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

21 authors at 5 institutions in 3 countries.

Pasquale SansoneDepartment of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10021; pasquale_s2002@yahoo.it giuseppe.gasparre@gmail.com bromberj@mskcc.org.ORCID 0000-0001-5962-8351
Claudia SaviniDepartment of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10021.
Ivana KurelacDepartment of Medical and Surgical Sciences, Università di Bologna, Bologna, 40138, Italy.
Qing ChangDepartment of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10021.
Laura Benedetta AmatoDepartment of Medical and Surgical Sciences, Università di Bologna, Bologna, 40138, Italy.
Antonio StrillacciDepartment of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10021.
Anna StepanovaSchool of Biological Sciences, Queens University Belfast, Belfast BT9 7BL, United Kingdom.
Luisa IommariniDepartment of Pharmacy and Biotechnology Alma Mater Studiorum, Università di Bologna, Bologna, 40138, Italy.
Chiara MastroleoDepartment of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10021.
Laura DalyDepartment of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10021.
Alexander GalkinSchool of Biological Sciences, Queens University Belfast, Belfast BT9 7BL, United Kingdom.
Basant Kumar ThakurChildren's Cancer and Blood Foundation Laboratories, Weill Cornell Medicine, New York, NY 10065.
Nadine SoplopDepartment of Medicine, Weill Cornell Medicine, New York, NY 10065.
Kunihiro UryuDepartment of Medicine, Weill Cornell Medicine, New York, NY 10065.
Ayuko HoshinoChildren's Cancer and Blood Foundation Laboratories, Weill Cornell Medicine, New York, NY 10065.
Larry NortonDepartment of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10021.
Massimiliano BonaféDepartment of Experimental, Diagnostic and Specialty Medicine, Policlinico Universitario Sant' Orsola-Malpighi, 40138 Bologna BO, Italy.
Monica CriccaDepartment of Experimental, Diagnostic and Specialty Medicine, Policlinico Universitario Sant' Orsola-Malpighi, 40138 Bologna BO, Italy.
Giuseppe GasparreDepartment of Medical and Surgical Sciences, Università di Bologna, Bologna, 40138, Italy; pasquale_s2002@yahoo.it giuseppe.gasparre@gmail.com bromberj@mskcc.org.
David LydenChildren's Cancer and Blood Foundation Laboratories, Weill Cornell Medicine, New York, NY 10065.
Jacqueline BrombergDepartment of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10021; pasquale_s2002@yahoo.it giuseppe.gasparre@gmail.com bromberj@mskcc.org.
Memorial Sloan Kettering Cancer Center · USUniversity of Bologna · ITCornell University · USIRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola · ITQueen's University Belfast · GB

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Nicholas D Socci · 1985 to 2026
$347.4M
Characterization and Functional Analysis of Breast Cancer Secreted Exosomes in MaU01CA169538 · NCI · WEILL MEDICAL COLL OF CORNELL UNIV · PI BISSELL, MINA, LYDEN, DAVID CHARLES · 2012 to 2016
$2.9M
Medical Research Council MR/L007339/1NCI NIH HHS P30 CA008748NCI NIH HHS U01 CA169538
6 · The paper itself

Abstract

The horizontal transfer of mtDNA and its role in mediating resistance to therapy and an exit from dormancy have never been investigated. Here we identified the full mitochondrial genome in circulating extracellular vesicles (EVs) from patients with hormonal therapy-resistant (HTR) metastatic breast cancer. We generated xenograft models of HTR metastatic disease characterized by EVs in the peripheral circulation containing mtDNA. Moreover, these human HTR cells had acquired host-derived (murine) mtDNA promoting estrogen receptor-independent oxidative phosphorylation (OXPHOS). Functional studies identified cancer-associated fibroblast (CAF)-derived EVs (from patients and xenograft models) laden with whole genomic mtDNA as a mediator of this phenotype. Specifically, the treatment of hormone therapy (HT)-naive cells or HT-treated metabolically dormant populations with CAF-derived mtDNA

Indexed as

Breast NeoplasmsCell Line, TumorDNA, MitochondrialDrug Resistance, NeoplasmExosomesFemaleFibroblastsGene Transfer, HorizontalGenome, MitochondrialHumansMCF-7 CellsNADH DehydrogenaseOxidative PhosphorylationReceptors, EstrogenXenograft Model Antitumor AssaysDNA, MitochondrialNADH DehydrogenaseNADH dehydrogenase subunit 1, humanReceptors, Estrogencancer stem cellsexosomeshormonal therapymetastasismitochondrial DNA

Identifiers

PMID29073103
PMCPMC5664494
OpenAlexW2761458899

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.